LifeStance Health Group (LFST) Stock: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$11.91
-0.12 (-1.00%)
▼
5d:
+0.93%
30d:
-5.48%
90d:
+5.68%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LFST shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LFST shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.08
21.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $11.91, which is considered oversold relative to its 30-day fair value range of $12.04 to $12.89. The stock's valuation (Forward PE: 22.4) is in line with its historical norms (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This pessimistic expectation contrasts with the company's recent 1927.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, LFST is in a strong uptrend. The price is currently testing key support at $11.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LFST scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.20 (+19.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LFST is in a strong uptrend. The price is currently testing key support at $11.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LFST scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.20 (+19.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.04 -
$12.89
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($14.20)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$12.04 -
$12.89
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$11.60
Resistance Level
$12.91
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.44
Wall Street Target
$14.20
(+19.2%)
Revenue Growth (YoY)
26.1%
Earnings Growth (YoY)
1927.5%
Profit Margin
3.2%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
22.4 vs 23.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$11.73
(-2%)
2-Year Target
$11.56
(-3%)
3-Year Target
$11.38
(-4%)
3-Yr Target (if PE normalizes)
(PE: 22→24)
$11.92
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 34.2%)
$28.79
(+142%)
Base:
(SPY PE: 20.4, Growth: 34.2%)
$26.18
(+120%)
Bear:
(PE: 17.3, Growth: 34.2%)
$22.25
(+87%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (53x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Forward PE: 52.63 | Forward EPS (Implied): $0.23
Bull Case
$14.38
(+21%)
Analyst growth 15.0%, PE expands to 55.3
Base Case
$11.91
(0%)
Market implied 0.0%, PE stable at 52.6
Bear Case
$9.11
(-24%)
Severe decline -15.0%, PE contracts to 47.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.4 to 23.5
Stabilization Target:
$12.47
(+4.7%)
PE Expansion Potential:
+4.7%
Share & Embed Analysis
Last updated: October 01, 2026 9:55 PM ET
Data refreshes hourly during market hours. Next update: 10:55 PM
Data refreshes hourly during market hours. Next update: 10:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 46 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 53 HOLD |
